BUDGET IMPACT ANALYSIS OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR TREATMENT OF DIABETIC MACULAR OEDEMA IN SPAIN

被引：0
|
作者：
de Andres-Nogales, F. [1 ]
Oyaguez, I [1 ]
Echave, M. [1 ]
Arias, L. [2 ]
Cervera, E. [3 ]
Armada, F. [4 ]
Martinez, C. [5 ]
机构：
[1] Pharmacoecon & Outcomes Res Iberia, Pozuelo De Alarcon, Madrid, Spain
[2] Hosp Univ Bellvitge, Lhospitalet De Llobregat, Spain
[3] Hosp Gen Univ Valencia, Valencia, Spain
[4] Hosp Univ La Paz, Madrid, Spain
[5] Allergan SAU, Tres Cantos, Spain
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.1263
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS19
引用
收藏
页码：A565 / A565
页数：1
相关论文
共 50 条
  • [1] Budget impact analysis of dexamethasone intravitreal implant for the treatment of diabetic macular oedema
    Cervera, Enrique
    de Andres-Nogales, Fernando
    Armada, Felix
    Arias, Luis
    Oyaguez, Itziar
    Martinez, Concha
    [J]. FARMACIA HOSPITALARIA, 2018, 42 (06) : 244 - 250
  • [2] INTRAVITREAL DEXAMETHASONE IMPLANT IN EYES WITH CHRONIC REFRACTORY DIABETIC MACULAR OEDEMA
    Giralt, Juan
    Alforja, Socorro
    Keller, Johannes
    Latasiewicz, Marta
    Fontecilla, Christian
    Adan Civera, Alfredo
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [3] Dexamethasone intravitreal implant in the treatment of diabetic macular edema
    Dugel, Pravin U.
    Bandello, Francesco
    Loewenstein, Anat
    [J]. CLINICAL OPHTHALMOLOGY, 2015, 9 : 1321 - 1335
  • [4] Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema
    Mehta, Hemal
    Gillies, Mark
    Fraser-Bell, Samantha
    [J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2015, 6 (05) : 234 - 245
  • [5] EFFECT OF DEXAMETHASONE INTRAVITREAL IMPLANT, OZURDEX®, ON DIABETIC MACULAR OEDEMA DURING PREGNANCY
    Ba-Ali, S.
    Valerius, M.
    Hodzic-Hadzibegovic, D.
    Tornes, M. H.
    Lund-Andersen, H.
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2016, 26 (04) : E110 - E110
  • [6] The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular oedema
    Maria Vittoria Cicinelli
    Amir Rosenblatt
    Domenico Grosso
    Piero Zollet
    Luigi Capone
    Alessandro Rabiolo
    Rosangela Lattanzio
    Anat Loewenstein
    Francesco Bandello
    [J]. Eye, 2021, 35 : 3232 - 3242
  • [7] Retinal vascular calibre changes after intravitreal bevacizumab or dexamethasone implant treatment for diabetic macular oedema
    Wickremasinghe, Sanjeewa S.
    Fraser-Bell, Samantha
    Alessandrello, Elizabeth
    Mehta, Hemal
    Gillies, Mark C.
    Lim, Lyndell L.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2017, 101 (10) : 1329 - 1333
  • [8] Efficacy of dexamethasone intravitreal implant for the treatment of diabetic macular edema
    Bonnin, Sophie
    Dupas, Benedicte
    El Sanharawi, Mohamed
    Perol, Julien
    Erginay, Ali
    Tadayoni, Ramin
    Massin, Pascale
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2015, 25 (05) : 448 - 453
  • [9] PHARMACOECONOMIC ANALYSIS OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF DIABETIC MACULAR EDEMA IN RUSSIA
    Kolbin, A.
    Galankin, T.
    Kaleev, A., I
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A158 - A158
  • [10] Morphological and functional changes in recalcitrant diabetic macular oedema after intravitreal dexamethasone implant
    Iacono, Pierluigi
    Parodi, Maurizio Battaglia
    Scaramuzzi, Matteo
    Bandello, Francesco
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2017, 101 (06) : 791 - 795
12345